Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
European Journal of Medicinal Chemistry
|
October 1, 2018
A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors
Marion Gay, Caroline Evrard, Florian Descamps, et al.
Cellular and Molecular Life Sciences : CMLS
|
June 13, 2022
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
Erika Cecon, Daniela Fernandois, Nicolas Renault, et al.
European Journal of Medicinal Chemistry
|
April 16, 2022
Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction
Raphaël Le Biannic, Romain Magnez, Frédérique Klupsch, et al.
European Journal of Medicinal Chemistry
|
August 7, 2022
High ligand efficiency quinazoline compounds as novel A<sub>2A</sub> adenosine receptor antagonists
Raphaël Bolteau, Romain Duroux, Amélie Laversin, et al.
Journal of Medicinal Chemistry
|
July 19, 2025
Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties
Emeline Charnelle, Alexandre Gobert, Romain Marteau, et al.
Cancers
|
November 27, 2021
The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell Tumorigenesis
Nicolas Stoup, Maxime Liberelle, Céline Schulz, et al.
Cancers
|
May 9, 2018
Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface
Floriane Gibault, Mathilde Coevoet, Manon Sturbaut, et al.
Bioorganic & Medicinal Chemistry
|
July 16, 2013
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
Aurélien Tourteau, Virginie Andrzejak, Mathilde Body-Malapel, et al.
ACS Pharmacology & Translational Science
|
February 20, 2025
Characterization of the Active Enantiomer and Mapping of the Stereospecific Intermolecular Pattern of a Reference P2X7 Allosteric Antagonist
Andrew McGown, Nicolas Renault, Amélie Barczyk, et al.
Kidney International
|
December 18, 2009
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
Frank Bienaime, Marie-Agnes Dragon-Durey, Catherine H Regnier, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
European Journal of Medicinal Chemistry
|
October 1, 2018
A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors
Marion Gay, Caroline Evrard, Florian Descamps, et al.
Cellular and Molecular Life Sciences : CMLS
|
June 13, 2022
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
Erika Cecon, Daniela Fernandois, Nicolas Renault, et al.
European Journal of Medicinal Chemistry
|
April 16, 2022
Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction
Raphaël Le Biannic, Romain Magnez, Frédérique Klupsch, et al.
European Journal of Medicinal Chemistry
|
August 7, 2022
High ligand efficiency quinazoline compounds as novel A<sub>2A</sub> adenosine receptor antagonists
Raphaël Bolteau, Romain Duroux, Amélie Laversin, et al.
Journal of Medicinal Chemistry
|
July 19, 2025
Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties
Emeline Charnelle, Alexandre Gobert, Romain Marteau, et al.
Cancers
|
November 27, 2021
The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell Tumorigenesis
Nicolas Stoup, Maxime Liberelle, Céline Schulz, et al.
Cancers
|
May 9, 2018
Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface
Floriane Gibault, Mathilde Coevoet, Manon Sturbaut, et al.
Bioorganic & Medicinal Chemistry
|
July 16, 2013
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis
Aurélien Tourteau, Virginie Andrzejak, Mathilde Body-Malapel, et al.
ACS Pharmacology & Translational Science
|
February 20, 2025
Characterization of the Active Enantiomer and Mapping of the Stereospecific Intermolecular Pattern of a Reference P2X7 Allosteric Antagonist
Andrew McGown, Nicolas Renault, Amélie Barczyk, et al.
Kidney International
|
December 18, 2009
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
Frank Bienaime, Marie-Agnes Dragon-Durey, Catherine H Regnier, et al.
Page
of 5